Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Strategies for Assessing and Addressing Confounding01:25

Strategies for Assessing and Addressing Confounding

Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A randomized controlled trial of staged cardiac rehabilitation based on the Health Belief Model on kinesiophobia, self-efficacy and activities of daily living in elderly patients with coronary heart disease.

Frontiers in medicine·2026
Same author

Propagating Cross-View Semantics for Multi-view Clustering: A Unified Anchor Refinement Paradigm.

IEEE transactions on pattern analysis and machine intelligence·2026
Same author

Spatial transcriptomics in cancer research: insights into tumorigenesis, diagnosis and therapeutics.

Cell death discovery·2026
Same author

The ArMAPK5-ArbHLH3-Ar4CL3 module is associated with salicylic acid-induced phenolic biosynthesis in Agastache rugosa.

Plant physiology and biochemistry : PPB·2026
Same author

A novel two-in-one Eu-MOFs integrates electrochemiluminescence and ratiometric fluorescence dual-mode sensor for tetracycline detection.

Biosensors & bioelectronics·2026
Same author

A heterozygous deletion and inversion at the NHEJ1‑IHH locus associated with shank length in Yunlong short-leg chicken.

BMC genomics·2026

Related Experiment Video

Updated: Jul 11, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Strong compound-risk factors: efficient discovery through emerging patterns and contrast sets.

Jinyan Li1, Qiang Yang

  • 1Institute for Infocomm Research, Singapore 119613. jyli@ntu.edu.sg

IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society
|October 5, 2007
PubMed
Summary

This study introduces compound-risk factors, linking statistical measures like odds ratio (OR) and risk ratio (RR) to data mining patterns. This enables efficient discovery of complex risk factors in large datasets.

More Related Videos

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Related Experiment Videos

Last Updated: Jul 11, 2026

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow
09:04

Identifying Per- and Polyfluorinated Chemical Species with a Combined Targeted and Non-Targeted-Screening High-Resolution Mass Spectrometry Workflow

Published on: April 18, 2019

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

Area of Science:

  • Biostatistics
  • Data Mining
  • Machine Learning

Background:

  • Traditional biostatistics measures like odds ratio (OR), relative risk (RR), and absolute risk reduction (ARR) are used for identifying risk factors in dichotomous groups.
  • These measures have primarily been applied to simple risk factors, limiting their scope in assessing complex factor interplays.

Purpose of the Study:

  • To introduce the concept of compound-risk factors to expand the application of statistical tests for analyzing factor interplays.
  • To establish a novel link between compound-risk factors and pattern mining concepts such as strong emerging patterns and strong contrast sets.
  • To propose a unified framework and algorithm for efficiently discovering compound-risk factors based on OR, RR, or ARR thresholds.

Main Methods:

  • Development of a theoretical framework for unifying the discovery of compound-risk factors.
  • Introduction of a new algorithm designed for efficient discovery of compound-risk factors meeting specified thresholds.
  • Demonstration of the algorithm's capability to find patterns corresponding to strong OR, RR, or ARR.

Main Results:

  • Established a previously unknown one-to-one correspondence between compound-risk factors with high RR or ARR and strong emerging patterns/contrast sets.
  • Proposed an efficient algorithm that guarantees discovery of all patterns meeting a given test threshold.
  • Showcased the first successful integration of risk ratios and ORs with pattern mining algorithms for large-scale data analysis.

Conclusions:

  • The proposed method enables efficient discovery of compound-risk factors in large datasets by linking statistical measures to pattern mining.
  • Compound-risk factors effectively capture interdependencies between data attributes, leading to improved classification accuracy in probabilistic learning algorithms for disease data.